Health
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection – Wiley
Click on the article title to read more.
We describe evolution of persistent immune thrombocytopaenic purpura (ITP) from acute ITP in a young woman with clinically otherwise inapparent severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection (COVID19); her development of ITP was matter for an earlier report.[1] ITP is an acquired disease in which thrombocytopaenia results from autoantibodies against platelet antigens. Approximately 10% of patients with acute ITP develop persistent (lasting 312 months) or chronic (>12 months)…
-
Business23 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News19 hours agoWilliam Robinson dies aged 89
-
Business23 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Noosa News20 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats